Working Meeting of Nanjing Meirui Separation and Integration Successfully Held
On July 12th, 2016, Trade Star Group and GSK separation working team held a working meeting regarding acquisition, separation and integration of Nanjing Meirui Pharmaceuticals Co., Ltd. in Shanghai Meridian Hotel. A total of over 20 people, including the integration working team, led by Dr. Li Chao, the chairman of our Group, comprised of relevant staff from administration and human resources, finance, IT, commerce and investment, together with Ms. Joanne, GSK project manager as well as members from GSK separation team, attended the meeting.
In the meeting, the Investment Director of our Group introduced the general introduction of Trade Star Group as well as the future development plan of Meirui, and the responsible person of Nanjing Meirui site introduced the current operation situations. Both teams carried out conscientious discussions on the separation and integration workstream plan of Nanjing Meirui and critical transition items during the transition period, evaluated existing issues and risks during the period, and explored the approaches to solving problems and reducing risks.
Through this meeting, both sides were able to fully understand the separation and integration plan and critical items during the transition, but also we were encouraged to have faith in the future development prosperity of Nanjing Meirui, which laid a good foundation for the successful transition of Nanjing Meirui.
Joanne, GSK Project Manager, is introducing the separation and integration plan
Snapshot of separation and integration working meeting